HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
1326studies shown
Showing 1,129-1,140 of 1,326
Drug study icon
WithdrawnNCT00781794

Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients

Official study title

A Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of Single Oral Doses of NSA-789 on Auditory P50 Suppression in Nonsmoking Patients With Stabilized Schizophrenia

This study was withdrawn before enrollment.

In France
SchizophreniaMedication studyAges 18–55
Countries
France, United States
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Other study type icon
CompletedNCT05365295

ADHD Children's Sensitivity to Memory Error Production

Official study title

Sensitivity of Children With Attention Deficit/Hyperactivity Disorder to Memory Error Production

This study has finished and is no longer accepting participants.

In France
ADHDInterventional studyAges 8–11
Countries
France
Sponsor
University Hospital, Angers
Other study type icon
CompletedNCT05268965

Affective Forecasting Skills in PTSD

Official study title

Autonomic and Subjective Correlates of Affective Forecasting Skills in Post-traumatic Stress Disorder

This study has finished and is no longer accepting participants.

In France
PTSDObservational studyAges 18–60
Countries
France
Sponsor
University Hospital, Lille
Other study type icon
CompletedNCT06056414

Anxiety After a Session of Energy Resonance by Cutaneous Stimulation

Official study title

Study of the Reduction of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation in the Management of Patients Requiring Breast Macrobiopsy.

This study has finished and is no longer accepting participants.

In France
AnxietyInterventional studyAges 18+
Countries
France
Sponsor
Centre Henri Becquerel
Drug study icon
CompletedNCT00257972

Aripiprazole in people with Bipolarity type I

What is this study about?

This study evaluated the effectiveness of aripiprazole for people with bipolarity.

This study has finished and is no longer accepting participants.

In France
BipolarityMedication studyAges 18+
Countries
France, United States, Australia, + 14 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT00861796

CYR-101 in people with Schizophrenia

What is this study about?

Researchers compared CYR-101 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

In France
SchizophreniaMedication studyAges 18–65
Countries
France
Sponsor
Cyrenaic Pharmaceuticals
Other study type icon
CompletedNCT05216705

Exploratory Plasmatic Markers of Alcohol Withdrawal

Official study title

Study of Exploratory Plasmatic Markers of Alcohol Withdrawal

This study has finished and is no longer accepting participants.

In France
AddictionObservational studyAges 18–65
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Other study type icon
UnknownNCT03519035

Hallucinations in people with Borderline Personality Disorder

Official study title

Study of Prevalence and Characteristics of Hallucinations in Patients With Borderline Personality Disorder

Current recruitment status is unconfirmed.

In France
Personality disordersObservational studyAges 18–75
Countries
France
Sponsor
University Hospital, Toulouse

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.